Literature DB >> 23510323

Heat-shock factor 1 both positively and negatively affects cellular clonogenic growth depending on p53 status.

Chau H Nguyen1, Benjamin J Lang, Ryan C C Chai, Jessica L Vieusseux, Michelle M Kouspou, John T Price.   

Abstract

HSF1 (heat-shock factor 1) is the master regulator of the heat-shock response; however, it is also activated by cancer-associated stresses and supports cellular transformation and cancer progression. We examined the role of HSF1 in relation to cancer cell clonogenicity, an important attribute of cancer cells. Ectopic expression or HSF1 knockdown demonstrated that HSF1 positively regulated cancer cell clonogenic growth. Furthermore, knockdown of mutant p53 indicated that HSF1 actions were mediated via a mutant p53-dependent mechanism. To examine this relationship more specifically, we ectopically co-expressed mutant p53(R273H) and HSF1 in the human mammary epithelial cell line MCF10A. Surprisingly, within this cellular context, HSF1 inhibited clonogenicity. However, upon specific knockdown of endogenous wild-type p53, leaving mutant p53(R273H) expression intact, HSF1 was observed to greatly enhance clonogenic growth of the cells, indicating that HSF1 suppressed clonogenicity via wild-type p53. To confirm this we ectopically expressed HSF1 in non-transformed and H-Ras(V12)-transformed MCF10A cells. As expected, HSF1 significantly reduced clonogenicity, altering wild-type p53 target gene expression levels consistent with a role of HSF1 increasing wild-type p53 activity. In support of this finding, knockdown of wild-type p53 negated the inhibitory effects of HSF1 expression. We thus show that HSF1 can affect clonogenic growth in a p53 context-dependent manner, and can act via both mutant and wild-type p53 to bring about divergent effects upon clonogenicity. These findings have important implications for our understanding of HSF1's divergent roles in cancer cell growth and survival as well as its disparate effect on mutant and wild-type p53.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510323     DOI: 10.1042/BJ20130098

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  The Helicobacter pylori cytotoxin CagA is essential for suppressing host heat shock protein expression.

Authors:  Ben J Lang; Rebecca J Gorrell; Mona Tafreshi; Masanori Hatakeyama; Terry Kwok; John T Price
Journal:  Cell Stress Chaperones       Date:  2016-03-01       Impact factor: 3.667

Review 2.  Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.

Authors:  Agnieszka Toma-Jonik; Natalia Vydra; Patryk Janus; Wiesława Widłak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-10       Impact factor: 6.730

3.  HSF-1-mediated cytoskeletal integrity determines thermotolerance and life span.

Authors:  Nathan A Baird; Peter M Douglas; Milos S Simic; Ana R Grant; James J Moresco; Suzanne C Wolff; John R Yates; Gerard Manning; Andrew Dillin
Journal:  Science       Date:  2014-10-17       Impact factor: 47.728

4.  Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.

Authors:  Ryan C Chai; Michelle M Kouspou; Benjamin J Lang; Chau H Nguyen; A Gabrielle J van der Kraan; Jessica L Vieusseux; Reece C Lim; Matthew T Gillespie; Ivor J Benjamin; Julian M W Quinn; John T Price
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

5.  Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.

Authors:  Cecilia W Huo; Mark Waltham; Christine Khoo; Stephen B Fox; Prue Hill; Shou Chen; Grace L Chew; John T Price; Chau H Nguyen; Elizabeth D Williams; Michael Henderson; Erik W Thompson; Kara L Britt
Journal:  Breast Cancer Res       Date:  2016-10-25       Impact factor: 6.466

6.  NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer.

Authors:  Yifang Wei; Shentong Yu; Yongping Zhang; Yuan Zhang; Huadong Zhao; Zhixiong Xiao; Libo Yao; Suning Chen; Jian Zhang
Journal:  Oncotarget       Date:  2017-04-25

7.  Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females.

Authors:  Sahar Almotwaa; Mohamed Elrobh; Huda AbdulKarim; Mohamed Alanazi; Sooad Aldaihan; Jilani Shaik; Maha Arafa; Arjumand Sultan Warsy
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

Review 8.  Mutant p53 in cancer: new functions and therapeutic opportunities.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

Review 9.  HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity.

Authors:  Thomas L Prince; Benjamin J Lang; Martin E Guerrero-Gimenez; Juan Manuel Fernandez-Muñoz; Andrew Ackerman; Stuart K Calderwood
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

Review 10.  Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors.

Authors:  Hui Li; Jinglin Zhang; Joanna Hung Man Tong; Anthony Wing Hung Chan; Jun Yu; Wei Kang; Ka Fai To
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.